Cancer Treatment Market Research Reports & Industry Analysis
Cancer is a disease characterized by uncontrolled cell proliferation. Of the more than 100 types of cancer, lung, breast, and colorectal cancer account for nearly half of new cases per year in the United States. Lung cancer, which is highly correlated with cigarette smoking, is responsible for more deaths than any other form of cancer. Cigarette smoking and other environmental factors are associated with the majority of cancers.
With the growing incidence of cancer, a growing and aging world population and significant medical advances, there will continue to be phenomenal growth in the market for cancer diagnosis and treatment products.
Cancer Treatment Industry Research & Market Reports
-
Artificial Intelligence in the Cancer Market
... around since the 1950s, but it has seen an increase in recent years due to significant advancements in computing power. There are currently examples of AI all around us every day, from voice-enabled assistants like ... Read More
-
Advanced Recurrent Ovarian Cancer- Pipeline Insight, 2022
... the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this ... Read More
-
Cancer Therapy - Market Insights, Competitive Landscape and Market Forecast–2027
... Cancers, And Others), By End User (Hospitals, Specialty Clinics, And Others), and by geography is expected to advance at a respectable CAGR forecast till 2026 owing to rising prevalence of various cancers such as lung ... Read More
-
Complementary and Alternative Medicine Market By Type (Medicines, Therapy), By Disease Indication (Diabetes, Cardiovascular, Neurology, Cancer, Arthritis, Others), By Distribution Channels (Direct Sales, Online Sales, Distance Correspondence): Global Opportunity Analysis and Industry Forecast, 2021-2031
... global complementary and alternative medicine market was valued at $101,995.95 million in 2021 and is projected to reach $437,864.92 million by 2031, registering a CAGR of 15.6% from 2022 to 2031 The term complementary and ... Read More
-
Esophageal Cancer- Pipeline Insight, 2022
... and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global coverage Esophageal ... Read More
-
Cancer Biomarkers Market, by Biomarker Type (Protein Biomarkers, Genetic Biomarkers, and Other Cancer Biomarkers), by Cancer Type (Breast Cancer, Lung Cancer, Prostate Cancer, Kidney Cancer, Liver Cancer, and Other Cancers), by End User (Hospitals, Academic and Cancer Research Institutes, Ambulatory Surgical Centers, and Cancer Diagnostic Laboratories), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... and Cancer Research Institutes, Ambulatory Surgical Centers, and Cancer Diagnostic Laboratories), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030 ... Read More
-
Esophageal Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... provides an overview of the Esophageal Cancer (Oncology) pipeline landscape. Esophageal cancer is cancer that occurs in the esophagus. Symptoms include cough, difficulty swallowing, chest pain, pressure or burning and weight loss. Predisposing factors include ... Read More
-
Uveal Melanoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... provides an overview of the Uveal Melanoma (Oncology) pipeline landscape. Uveal melanoma, the most common intraocular tumor, is a disease in which cancer (malignant) cells are found in the part of the eye called the ... Read More
-
Human Papillomavirus (HPV) Associated Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Cancer – Drugs In Development, 2022, provides an overview of the Human Papillomavirus (HPV) Associated Cancer (Oncology) pipeline landscape. Human papillomavirus (HPV) is the most common viral infection of the reproductive tract. Human papillomavirus (HPV) ... Read More
-
Peritoneal Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... provides an overview of the Peritoneal Cancer (Oncology) pipeline landscape. Peritoneal cancer is a rare cancer that develops in the peritoneum, a thin, delicate sheet that lines the inside wall of the abdomen and covers ... Read More
-
Dermatology Devices Market by Type (Diagnostic Devices (Dermatoscopes, Imaging Devices), Treatment Devices (Laser, Cryotherapy, Liposuction), Application (Skin Cancer, Acne, Psoriasis, Skin Rejuvenation, Tattoo Removal) - Global Forecast to 2027
... projected to reach USD 11.3 billion by 2027 from USD 6.2 billion in 2022, at a CAGR of 12.7% during the forecasted period. Dermatology devices help dermatologists and surgeons in diagnosing and treating skin disorders. ... Read More
-
Colorectal Cancer Epidemiology Analysis and Forecast, 2021-2031
... malignancy originating from either the colon or the rectum. CRC is the second most lethal cancer after lung cancer, and the third most diagnosed malignant tumor worldwide (World Health Organization, 2022). The disease usually begins ... Read More
-
Metastatic Melanoma Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
... provides an overview of Metastatic Melanoma Clinical trials scenario. This report provides top line data relating to the clinical trials on Metastatic Melanoma. Report includes an overview of trial numbers and their average enrollment in ... Read More
-
Ewing Sarcoma Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
... provides an overview of Ewing Sarcoma Clinical trials scenario. This report provides top line data relating to the clinical trials on Ewing Sarcoma. Report includes an overview of trial numbers and their average enrollment in ... Read More
-
Next-Generation Oncology Devices and Solutions Market - A Global and Regional Analysis: Focus on Clinical Application, End User, Type, and Region - Analysis and Forecast, 2022-2031
... The global next-generation oncology devices and solutions market report highlights that the market was valued at $3,268.2 million in 2021 and is expected to reach $5,971.3 million by the end of 2031. The market is ... Read More
-
Cervical Cancer Therapeutics Market - Epidemiology & Pipeline Analysis 2022-2027
... are formed in the tissues of the cervix, the lower part of the uterus that connects to the vagina. Human papillomavirus (HPV) infection is the major risk factor for cervical cancer. According to Arizton's estimates, ... Read More
-
Global Salivary Gland Cancer Treatment Market - 2022-2029
... growing at a CAGR of XX % during the forecast period (2022-2029). Salivary gland cancer is rare cancer that develops in the tissue of the salivary glands. These glands control the production of saliva. A ... Read More
-
Global Cancer Cachexia Market - 2022-2029
... weight loss, anorexia, asthenia, and anemia. The pathogenicity of this syndrome is multifactorial, due to a complex interaction of tumor and host factors. The signs and symptoms of cachexia are considered the prognostic parameters in ... Read More
-
Biosimilars Market Size By Product (Recombinant Non-Glycosylated Proteins {Human Growth Hormone, Granulocyte Colony-Stimulating Factor, Insulin, Interferon}, Recombinant Glycosylated Proteins {Erythropoietin, Monoclonal Antibodies, Follitropin, Low Molecular Weight Heparin}), By Application (Hematology {Neutropenia, Anemia}, Oncology {Lung Cancer, Brain Cancer, Breast Cancer, Cervical Cancer, Colorectal Cancer, Leukemia or Blood Cancer}, Autoimmune Disease {Arthritis, Inflammatory Bowel Disease, Psoriasis}, Growth Hormone Deficiency, Diabetes), By Manufacturer (Contract Research and Manufacturing Services, In-house), By Technology (Recombinant DNA Technology, Monoclonal Antibodies Technology) Industry Analysis Report, Regional Outlook, Application Potential, COVID-19 Impact Analysis, Competitive Market Share & Forecast, 2022 - 2030
... Brain Cancer, Breast Cancer, Cervical Cancer, Colorectal Cancer, Leukemia or Blood Cancer}, Autoimmune Disease {Arthritis, Inflammatory Bowel Disease, Psoriasis}, Growth Hormone Deficiency, Diabetes), By Manufacturer (Contract Research and Manufacturing Services, In-house), By Technology (Recombinant DNA ... Read More
-
Global Tonsil Cancer Treatment Market - 2022-2029
... at a CAGR of XX% during the forecast period (2022-2029). Throat cancer is a form of neck and head cancer that affects the larynx, vocal cords, and other throat parts. Cough, change in voice, painful ... Read More
-
U.S. Opioids Market, by Drugs (Codeine, Fentanyl, Meperidine, Methadone, Morphine, and Hydrocodone), by Therapeutic Application (Pain Management (Neuropathic Pain, Migraine, Back Pain, Osteoarthritis Pain, Cancer Pain, and Others), Cough Treatment, and Diarrhea Treatment), and by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030 Opioids can be defined as a class of drugs, which include the drug heroin, synthetic opioids ... Read More
-
Brain Cancer Diagnostics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Diagnostic Type (Imaging Test [MRI, CT Scan, PET, and Others], Lumbar Puncture, Biopsy, Molecular Testing, Platform and Services [Sample Slide, Autosampler Unit, Solutions & Platform, and Services], Cerebral Arteriogram, Neurological & Hearing Tests/Neurocognitive Assessments, Electroencephalography (EEG), and Others); Cancer Type (Acoustic Neuroma, Astrocytomas, Craniopharyngiomas, Ganglioneuromas, Glioblastoma Multiforme, Meningiomas, Ependymomas, Oligodendroglioma, Low-Grade Tumors, and Others); End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Diagnostic Centers & Research Institutes, and Others); and Tumor Size (0.2 cm3 to 100 cm3, 101 cm3 to 200 cm3, and Above 200 cm3)
... Unit, Solutions & Platform, and Services], Cerebral Arteriogram, Neurological & Hearing Tests/Neurocognitive Assessments, Electroencephalography (EEG), and Others); Cancer Type (Acoustic Neuroma, Astrocytomas, Craniopharyngiomas, Ganglioneuromas, Glioblastoma Multiforme, Meningiomas, Ependymomas, Oligodendroglioma, Low-Grade Tumors, and Others); End User ... Read More
-
Liquid Biopsy Market (by Circulating Biomarker, Product, Application, End Users, Clinical Application, Cancer Types, Sample Type, Regional & Country Wise Analysis), Impact of COVID-19, Initiatives, Funding, Major Deals, Company Profiles and Recent Developments - Global Forecast to 2030
... Forecast to 2030 The global liquid biopsy market is predicted to surpass US$ 11 Billion by 2030. The advantages of liquid biopsy over solid tumor biopsy, rising prevalence of cancer, increasing preference for non-invasive procedures, ... Read More
-
Global Liposome Drug Delivery Market Size study, by Product (Liposomal Doxorubicin, Liposomal Paclitaxel, Liposomal Amphotericin B, and Others), by Technology (Stealth Liposome Technology, Non-PEGylated Liposome Technology, and DepoFoam Liposome Technology), by Application (Fungal Diseases, Pain Management, Cancer Therapy, Viral Vaccines, and Photodynamic Therapy) and Regional Forecasts 2022-2028
... Management, Cancer Therapy, Viral Vaccines, and Photodynamic Therapy) and Regional Forecasts 2022-2028Global Liposome Drug Delivery Market is valued at approximately USD XX million in 2021 and is anticipated to grow with a healthy growth rate ... Read More
-
Kidney Cancer Drugs Global Market Opportunities And Strategies To 2030: COVID-19 Growth And Change
... strategists; marketers and senior management with the critical information they need to assess the global kidney cancer drugs market as it emerges from the COVID 19 shut down. Reasons to Purchase Gain a truly global ... Read More
Research Assistance
